Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 98.30
-2.20 (-2.19%)
Aug 19, 2026, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 6.71 billion as of August 19, 2026. Its market cap has decreased by -43.22% in one year.
Market Cap
6.71B
Enterprise Value
4.43B
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
98.30
ChartMarket Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 6.71B, an increase of 161.73%. That is a compound annual growth rate of 17.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 6.71B | -66.94% |
| Dec 31, 2025 | 20.31B | 114.84% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.56B |
| Standard Chemical & Pharmaceutical | 10.97B |
| SCI Pharmtech | 6.33B |
| Formosa Laboratories | 6.18B |
| Orient Pharma | 5.34B |
| Panion & Bf Biotech | 5.02B |
| Orient EuroPharma | 4.20B |
| LIWANLI Innovation | 3.92B |